Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

HYDROHEAL · Multi-functional hydrogels for promoting bone fracture healing through local induced release of pharmaceutical agents and gradual matrix replacement by the regenerating bone

HORIZONStatus: SIGNED1 June 202531 May 2029EU funding €6,453,741Call HORIZON-CL4-2024-RESILIENCE-01-TWO-STAGE

Bone atrophy and fractures, resulting from trauma, infections, osteoporosis, or cancer, are global health concerns. Standard care with cement and bone grafts has limitations. Synthetic polymers like polymethyl methacrylate risk leakage, spinal issues, and poor healing. Donor shortages for allogenic bone grafting and invasive procedures pose risks such as rejection and viral transmission. HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.HYDROHEAL aims to develop safe, sustainable scaling, and cost-effective formulations using renewable biomaterials for targeted drug delivery, aligning closely with the EU Circular Economy Action Plan and Chemicals Strategy for Sustainability. It is ready to introduce a new era in fracture therapy. The proposed self-solidifying hydrogels release active pharmaceutical ingredients locally upon external stimulation, potentially improving treatment efficacy, preventing infections, and speeding up fracture healing.The objectives of the project are:1. Develop novel injectable hydrogel formulations combining natural substance derivates to enhance healing, inhibit bacterial growth, and monitor therapy progress in vivo.2. Simultaneously manufacture carriers as micro- and nano-particles, surface-functionalized to incorporate pharmaceutical agents, releaseable upon external stimuli for tailored drug release.3. Validate safe and optimized hydrogel formulations for treating vertebral and alveolar bone fractures through in vitro and in vivo tests.4. Demonstrate scalable and sustainable biomaterial manufacturing through safe design methods, machine learning, and predictive life cycle assessment.5. Develop machine learning and hybrid digital modeling methods, combining adaptive design of experiments and physics-based modeling with advanced characterization techniques.

Consortium · 13 organisations

coordinator

UNIVERSITAT POLITECNICA DE VALENCIA

ES · €891,824

participant

CONSULTECH TECHNOLOGIEBERATUNG GMBH

DE · €391,082

participant

CENTRE FOR PROCESS INNOVATION LIMITED LBG

UK · €893,771

participant

UNIVERSITY OF NEWCASTLE UPON TYNE

UK · €407,245

participant

UNIVERSITAT POLITECNICA DE CATALUNYA

ES · €499,816

participant

Separeco Srl

IT · €176,407

participant

VET EX MACHINA LIMITED

CY · €401,100

participant

SITEC PHARMABIO SL

ES · €424,994

participant

POLITECNICO DI TORINO

IT · €787,625

participant

FLUIDINOVA SA

PT · €168,371

participant

UNIVERSITY OF WARWICK

UK · €799,860

participant

ASPHALION SL

ES · €195,563

participant

ROYAL COLLEGE OF SURGEONS IN IRELAND

IE · €416,084

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.